Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

The presentation will take place on Tuesday, October 29^th at 9:40AM EDT at the Wyndham Grand Jupiter.

DEVON, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Vice President of Communications and Investor Relations, Will Roberts, will present a company overview at the Dawson James Securities 5th Annual Small Cap Growth Conference.

The presentation will take place on Tuesday, October 29^th at 9:40AM EDT at the Wyndham Grand Jupiter. A live webcast of the presentation will be accessible on the Investor Relations page of http://www.zynerba.com.